{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:13:42Z","timestamp":1792419222036,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T00:00:00Z","timestamp":1462320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Egyptian National Cancer Institute"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jnci.2016.04.007","type":"journal-article","created":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T13:45:27Z","timestamp":1464356727000},"page":"163-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Volumetric-modulated arc therapy (VMAT) versus 3D-conformal radiation therapy in supra-diaphragmatic Hodgkin\u2019s Lymphoma with mediastinal involvement: A dosimetric comparison"],"prefix":"10.1186","volume":"28","author":[{"given":"Christine","family":"Higby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Khafaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Al-Shabanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadeer","family":"Nazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab M.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"27","key":"10.1016\/j.jnci.2016.04.007_b0005","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2010.29.8018","article-title":"Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin\u2019s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial","volume":"28","author":"Eich","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jnci.2016.04.007_b0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1748-717X-7-186","article-title":"Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin\u2019s lymphoma: dosimetric comparison and clinical considerations","volume":"2","author":"Fiandra","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jnci.2016.04.007_b0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijrobp.2011.05.054","article-title":"Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy","volume":"83","author":"Koeck","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.jnci.2016.04.007_b0020","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","article-title":"Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","volume":"89","author":"Specht","year":"2014","journal-title":"Int J Radiat Oncol Biol"},{"key":"10.1016\/j.jnci.2016.04.007_b0025","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.canrad.2011.05.014","article-title":"Intensity-modulated radiotherapy and involved node concept in patients with Hodgkin lymphoma: experience of the Gustave-Roussy Institute","volume":"15","author":"Paumier","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.jnci.2016.04.007_b0030","doi-asserted-by":"crossref","unstructured":"Marks BM, Yorke ED, Jackson A, Haken RKT, Consine LS, Eisbrugh A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat. Oncol. Biol. Phys., 2010; 76(3), supplement: S10\u2013S19.","DOI":"10.1016\/j.ijrobp.2009.07.1754"},{"issue":"7","key":"10.1016\/j.jnci.2016.04.007_b0035","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin\u2019s lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.jnci.2016.04.007_b0040","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1200\/JCO.2004.12.170","article-title":"ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin\u2019s disease: long-term results","volume":"22","author":"Bonadonna","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jnci.2016.04.007_b0045","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1200\/JCO.2003.03.023","volume":"21","author":"Engert","year":"2003","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.jnci.2016.04.007_b0050","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1056\/NEJMoa064601","article-title":"Chemotherapy plus involved-field radiation in early stage Hodgkin\u2019s disease","volume":"357","author":"Ferm\u00e9","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jnci.2016.04.007_b0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijrobp.2015.02.008","article-title":"Expert radiation oncologist interpretations of involved-site radiation therapy guidelines in the management of Hodgkin lymphoma","volume":"92","author":"Hoppe","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.jnci.2016.04.007_b0060","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijrobp.2014.12.009","article-title":"Radiation therapy planning for early stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group","volume":"92","author":"Maraldo","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.jnci.2016.04.007_b0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2015.02.030","article-title":"Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk","volume":"92","author":"Filippi","year":"2015","journal-title":"Int Radiat Oncol Biol Phys"},{"issue":"14","key":"10.1016\/j.jnci.2016.04.007_b0070","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1200\/JCO.2010.32.8427","article-title":"Long-term complications of lymphoma and its treatment","volume":"29","author":"Ng","year":"2011","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.jnci.2016.04.007_b0075","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1200\/JCO.2008.20.7738","article-title":"Radiation dose and breast cancer risk in the childhood cancer survivor study","volume":"27","author":"Inskip","year":"2009","journal-title":"J Clin Oncol"},{"issue":"26","key":"10.1016\/j.jnci.2016.04.007_b0080","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1200\/JCO.2008.19.9174","article-title":"Breast cancer risk in female survivors of Hodgkin\u2019s lymphoma: lower risk after smaller radiation volumes","volume":"27","author":"De Bruin","year":"2009","journal-title":"J Clin Oncol"},{"issue":"28","key":"10.1016\/j.jnci.2016.04.007_b0085","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1200\/JCO.2007.11.2003","article-title":"Long-term health status among survivors of childhood cancer: does sex matter?","volume":"25","author":"Armstrong","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jnci.2016.04.007_b0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2015.01.013","article-title":"Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?","volume":"92","author":"Aznar","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jnci.2016.04.007_b0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1748-717X-9-94","article-title":"Dosimetric advantages of a \u2018butterfly\u201d technique for intensity-modulated radiotherapy for young female patients with mediastinal Hodgkin\u2019s lymphoma","volume":"9","author":"Voong","year":"2014","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.jnci.2016.04.007_b0100","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.meddos.2013.04.004","article-title":"Use of volumetric-modulated arc therapy for treatment of Hodgkin lymphoma","volume":"38","author":"Lee","year":"2013","journal-title":"Med Dosim"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110036216300267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110036216300267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T13:40:05Z","timestamp":1558618805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1110036216300267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1110036216300267"],"URL":"https:\/\/doi.org\/10.1016\/j.jnci.2016.04.007","relation":{},"ISSN":["1110-0362"],"issn-type":[{"value":"1110-0362","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Volumetric-modulated arc therapy (VMAT) versus 3D-conformal radiation therapy in supra-diaphragmatic Hodgkin\u2019s Lymphoma with mediastinal involvement: A dosimetric comparison","name":"articletitle","label":"Article Title"},{"value":"Journal of the Egyptian National Cancer Institute","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnci.2016.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 National Cancer Institute, Cairo University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}